Immunotherapy in hepatocellular carcinoma: how will it reshape treatment sequencing?

The treatment landscape of advanced hepatocellular carcinoma (HCC) has broadened with immune checkpoint inhibitors (ICIs) setting a novel standard of care. With the increased number of therapies either in first or in further line, disentangling the possible treatment sequences has become much more c...

Descripción completa

Detalles Bibliográficos
Autores principales: Cammarota, Antonella, Zanuso, Valentina, Manfredi, Giulia Francesca, Murphy, Ravindhi, Pinato, David James, Rimassa, Lorenza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837292/
https://www.ncbi.nlm.nih.gov/pubmed/36643654
http://dx.doi.org/10.1177/17588359221148029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837292/
https://www.ncbi.nlm.nih.gov/pubmed/36643654
http://dx.doi.org/10.1177/17588359221148029

Ejemplares similares